CG:600867 Tonghua Dongbao Pharmaceutical Co., Ltd

TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the manufacture and distribution of pharmaceuticals and construction materials. The Company's main products portfolio consists of recombinant human insulin bulk drugs and injections, zhennaoning capsules as well as dongbao gantai tablets, among others. It also involves in the provision of plastic-steel windows and profiles. The Company distributes its products in domestic and overseas markets.

10.36 CNY
As of 01/26/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-General
Index country:  China
Country of incorporation:  China
IPO date:  01/03/2000
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   21,011,116,032 CNY
Current dividend yield:   2.02%
Sedol:      6882428

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy